The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
Open accessAbstract
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death, reflecting the need for better understanding the oncogenesis, and developing new diagnostic and therapeutic targets for the malignancy. Emerging evidence suggests that small nucleolar RNAs (snoRNAs) have malfunctioning roles in tumorigenesis. Our recent study demonstrated that small nucleolar RNA 42 (SNORA42) was overexpressed in lung tumors. Here, we investigate the role of SNORA42 in tumorigenesis of NSCLC. We simultaneously assess genomic dosages and expression levels of SNORA42 and its host gene, KIAA0907, in 10 NSCLC cell lines and a human bronchial epithelial cell line. We then determine in vitro functional significance of SNORA42 in lung cancer cell lines through gain- and loss-of-function analyses. We also inoculate cancer cells with SNORA42-siRNA into mice through either tail vein or subcutaneous injection. We finally evaluate expression level of SNORA42 on frozen surgically resected lung tumor tissues of 64 patients with stage I NSCLC by using quantitative reverse transcriptase PCR assay. Genomic amplification and associated high expression of SNORA42 rather than KIAA0907 are frequently observed in lung cancer cells, suggesting that SNORA42 overexpression is activated by its genomic amplification. SNORA42 knockdown in NSCLC cells inhibits in vitro and in vivo tumorigenicity, whereas enforced SNORA42 expression in bronchial epitheliums increases cell growth and colony formation. Such pleiotropy of SNORA42 suppression could be achieved at least partially through increased apoptosis of NSCLC cells in a p53-dependent manner. SNORA42 expression in lung tumor tissue specimens is inversely correlated with survival of NSCLC patients. Therefore, SNORA42 activation could have an oncogenic role in lung tumorigenesis and provide potential diagnostic and therapeutic targets for the malignancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 3×
“Activation of p53 will induce growth arrest, differentiation, or apoptosis of cells (Vogelstein et al., 2000).”
BackgroundA microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967
Hayashita, Y., Osada, H., Tatematsu, Y., Yamada, H., Yanagisawa, K., Tomida, S., Yatabe, Y., Kawahara, K., Sekido, Y., & Takahashi, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2352 · Cited by 1,511
Moasser, M. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210477 · Cited by 1,219
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.-G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 831
Kiss (2002) · doi:10.1016/s0092-8674(02)00718-3 · Cited by 816
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F., & Williams, G. T. (2009) · Oncogene · doi:10.1038/onc.2008.373 · Cited by 775
The snoRNA HBII-52 Regulates Alternative Splicing of the Serotonin Receptor 2C
Kishore, S., & Stamm, S. (2006) · Science · doi:10.1126/science.1118265 · Cited by 702
Cited by
Pseudouridine profiling reveals regulated mRNA pseudouridylation in yeast and human cells
Carlile, T. M., Rojas-Duran, M. F., Zinshteyn, B., Shin, H., Bartoli, K. M., & Gilbert, W. V. (2014) · Nature · doi:10.1038/nature13802 · Cited by 1,021
Small non-coding RNA and cancer
Romano, G., Veneziano, D., Acunzo, M., & Croce, C. M. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx026 · Cited by 423
Are snoRNAs and snoRNA host genes new players in cancer?
Williams, G. T., & Farzaneh, F. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3195 · Cited by 362
Quantitative profiling of pseudouridylation dynamics in native RNAs with nanopore sequencing
Begik, O., Lucas, M. C., Pryszcz, L. P., Ramirez, J. M., Medina, R., Milenkovic, I., Cruciani, S., Liu, H., Vieira, H. G. S., Sas-Chen, A., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00915-6 · Cited by 312
Noncoding RNAs in eukaryotic ribosome biogenesis and function
Lafontaine, D. L. J. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2939 · Cited by 264
Metadata
- Authors
- Mei, Y.-P., Liao, J.-P., Shen, J., Yu, L., Liu, B.-L., Liu, L., Li, R.-Y., Ji, L., Dorsey, S. G., Jiang, Z.-R., Katz, R. L., Wang, J.-Y., & Jiang, F.
- Venue
- Oncogene
- Published
- 2011-10-10
- Volume
- 31
- Issue
- 22
- Pages
- 2794-2804
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2012372842
- Cited by
- 256
- References
- 36
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. https://app.cochat.ai/papers/10.1038/onc.2011.449
- The paper
- Mei, Y.-P., Liao, J.-P., Shen, J., Yu, L., Liu, B.-L., Liu, L., Li, R.-Y., Ji, L., Dorsey, S. G., Jiang, Z.-R., Katz, R. L., Wang, J.-Y., & Jiang, F. (2012). Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. https://doi.org/10.1038/onc.2011.449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.